Virax Biolabs Group Limited
VRAX
NASDAQ2.63
USD
+0.07
- -
Total Valuation
Virax Biolabs Group Limited carries a market capitalization of 489,891.00, placing it among publicly traded companies globally.
| Market Cap | 489,891.00 |
| Enterprise Value | N/A |
Stock Price Statistics
Virax Biolabs Group Limited's stock has declined approximately -82.69611% over the past 52 weeks. The 50-day moving average sits at 3.17, while the 200-day moving average is 5.59.
| Beta (5Y) | N/A |
| 52-Week Price Change | -82.69611% |
| 50-Day Moving Average | 3.17 |
| 200-Day Moving Average | 5.59 |
| Average Volume (20 Days) | N/A |
Stock Splits
Virax Biolabs Group Limited's most recent stock split took place on June 26, 2026 with a 25:1 split ratio.
| Last Split Date | 6/26/2026 |
| Split Ratio | 25:1 |